Neurotronic, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: NECTAR IV · Ablation of Arteries · Type 2 Diabetes Mellitus and Its Comorbidities Primary completion pushed from Jan 2025 to Jun 2027
- Notable: NECTAR III · Arterial Ablation · Type 2 Diabetes Mellitus and Its Comorbidities Primary completion pushed from Jan 2025 to May 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 |
Disease areas by active trials
Diabetes (2) · Hypertension (2) · Type 2 Diabetes (2)
Get alerts when Neurotronic, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.